Overall rank by patents
#4,308
Across all tracked assignees
USPTO PatentsView assignee record - 83 granted patents across 19 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
The holds 83 US patents across 19 technology areas, rank #4,308 of 50,000 tracked assignees.
The Wistar Institute Of Anatomy And Biology has been granted 83 US utility patents between 2015 and 2025, placing The Wistar Institute Of Anatomy And Biology at rank #4,308 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.5 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, The Wistar Institute Of Anatomy And Biology is one of the more focused assignees in the PatentsView dataset. By volume, The sits between Perceive Corporation (83 patents, rank #4,304) and Vonage Business Inc. (83 patents, rank #4,312) - the closest US assignees by grant volume. The composite Innovation Score of 45.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 53 grants, compared with 30 in the 2015–2019 window, a +77% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. The Wistar Institute Of Anatomy And Biology's 13.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark The Wistar Institute Of Anatomy And Biology against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Perceive Corporation
83 patents
TATSUTA ELECTRIC WIRE & CABLE CO., LTD.
83 patents
TOYOTA SHATAI KABUSHIKI KAISHA
83 patents
The Coleman Company, Inc.
83 patents
Theranos, Inc.
83 patents
UIF (University Industry Foundation), Yonsei University
83 patents
UNIVERSITY OF NORTH TEXAS
83 patents
Vonage Business Inc.
83 patents
The Wistar Institute of Anatomy and Biology
83 patents
What this shows The holds 83 patents at rank #4,308, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,308 in granted patent volume.
Other assignees with the most granted patents in The's primary technology class.
The's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 3.6% |
| 2016 | 3 | 3.6% |
| 2017 | 5 | 6.0% |
| 2018 | 7 | 8.4% |
| 2019 | 12 | 14.5% |
| 2020 | 3 | 3.6% |
| 2021 | 10 | 12.0% |
| 2022 | 6 | 7.2% |
| 2023 | 6 | 7.2% |
| 2024 | 13 | 15.7% |
| 2025 | 15 | 18.1% |
Top 15 of 19 technology areas
Overall rank by patents
#4,308
Across all tracked assignees
45.5 out of 100
How to use this portfolio
The's 83 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.